Video
Latham in Focus: Healthcare & Life Sciences Competition Considerations
July 7, 2025
What antitrust issues do healthcare and life sciences companies need to consider as they plan their next deal?
In this episode of Latham in Focus, Washington, D.C. partner Mandy Reeves, former Global Chair of Latham’s Band 1 Global Antitrust & Competition Practice, explores the impact of new HSR rules on healthcare and life sciences transactions. Mandy discusses how the new rules offer companies a chance to proactively engage with regulators, and covers what buyers should consider before signing a deal.